Interestingly, this was reflected in the patient prognosis, as patients with high CRK mRNA levels showed an increased survival and disease-free survival probability (although not significant), while patients with high CRKL expression had a significantly lower survival probability and earlier cancer recurrence (Figure 2D, Supplementary Figure S2C). The gene discussed is CRK; the disease is cancer.